<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000410212"><TermName>pioglitazone</TermName><TermPronunciation>(py-oh-GLIH-tuh-zone)</TermPronunciation><TermDefinition><DefinitionText>A drug that is used to treat type 2 diabetes and is being studied in the prevention of head and neck cancer. It may be able to stop leukoplakia (a condition affecting the mouth ) from developing into cancer. It is a type of thiazolidinedione. Also called Actos.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713092" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pioglitazone&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713091" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pioglitazona&quot;" language="es" id="_4"/><SpanishTermName>pioglitazona</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la diabetes tipo 2 y que está en estudio para prevenir el cáncer de cabeza y  cuello.; podría impedir que la leucoplaquia (afección que afecta la boca) se convierta en cáncer. Es un tipo de tiazolidinediona. También se llama Actos.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-05-23</DateFirstPublished><DateLastModified>2009-06-18</DateLastModified></GlossaryTerm>
